Skip to main content
. 2018 Mar 28;131(25):2826–2835. doi: 10.1182/blood-2017-09-804666

Figure 7.

Figure 7.

How is full reduction of KO to KH2accomplished during warfarin therapy? (A) VKORC1 normally performs 2 reactions to generate the KH2 cofactor required for VKD protein carboxylation. (B) During warfarin therapy, a warfarin-resistant quinone reductase may cooperate with VKORC1 to produce KH2.